All Stories

  1. Amino acid management of Parkinson's disease: a case study [Corrigendum]
  2. Relative nutritional deficiencies associated with centrally acting monoamines [Corrigendum]
  3. Parkinson’s disease-associated melanin steal
  4. Parkinson's disease: carbidopa, nausea, and dyskinesia
  5. The Parkinson's disease death rate: carbidopa and vitamin B6
  6. Tyrosine does not cause increased blood pressure
  7. Management of L-dopa overdose in the competitive inhibition state
  8. 5-HTP efficacy and contraindications
  9. Relative nutritional deficiencies associated with centrally acting monoamines
  10. The discrediting of the monoamine hypothesis
  11. Monoamine depletion by reuptake inhibitors
  12. APRESS: apical regulatory super system, serotonin, and dopamine interaction
  13. Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
  14. Microperforation prolotherapy: a novel method for successful nonsurgical treatment of atraumatic spontaneous anterior sternoclavicular subluxation, with an illustrative case
  15. Amino acid management of Parkinson’s disease: a case study
  16. Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
  17. Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
  18. Amino acid-responsive Crohn's disease: a case study
  19. A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
  20. Neurotransmitter testing of the urine: a comprehensive analysis
  21. The dual-gate lumen model of renal monoamine transport
  22. Abdominal Aortic Aneurysms in Association with Horseshoe Kidney